Ipamorelin

What is Ipamorelin?
Ipamorelin is a synthetic pentapeptide classified as a selective growth hormone secretagogue. It is studied for its activity at the growth hormone secretagogue receptor (GHSR-1a), also known as the ghrelin receptor, where it influences endogenous growth hormone signaling pathways.

Research Interest
Ipamorelin is being investigated in research on the neuroendocrine regulation of growth hormone release and downstream metabolic signaling. Areas of study include growth hormone pulsatility, insulin-like growth factor-1 (IGF-1) signaling, appetite-related pathways, and broader endocrine mechanisms associated with ghrelin receptor activity.

Mechanisms Under Investigation
Research suggests Ipamorelin stimulates growth hormone release through selective activation of ghrelin receptor signaling pathways. Unlike earlier secretagogues with broader endocrine activity, Ipamorelin has been studied for its relative receptor selectivity and its ability to influence physiologic growth hormone signaling with limited activity on other pituitary hormone pathways.

Current State of Research
Scientific literature on Ipamorelin includes preclinical investigation and human pharmacokinetic and pharmacodynamic research examining its receptor activity and endocrine signaling effects. Ongoing research explores ghrelin receptor biology and the broader physiological roles of selective growth hormone secretagogues.